All In Biotech

Drug Trial Radar · NCT05134441

Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 Versus Placebo in Adults With Relapsing Multiple Sclerosis (ENSURE-1)

Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,121 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,121

Actual

Start

Nov 18, 2021

Primary completion

Nov 2026

Study completion Sep 2033

Sponsor

Lead sponsor
Immunic AGIndustry
Sponsor type
Industry
First posted
Nov 26, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-1)

Conditions

  • Multiple Sclerosis

Interventions

  • IMU-838 tabletsDrug

    Patients are randomized to IMU-838 or placebo in ratio 1:1

  • Placebo matching IMU-838 tabletsDrug

    Patients are randomized to IMU-838 or placebo in ratio 1:1

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate efficacy of IMU-838 versus placebo regarding time to first relapseTime frame: 72 weeks

Locations

103 sites in 17 countries. Site status is shown where the registry gives one.

  • Xenoscience, Inc., 21st Century Neurology

    Phoenix, Arizona

  • Regina Berkovich MD, PhD Inc. MS Neurology

    West Hollywood, California

  • Bradenton Research Center

    Bradenton, Florida

  • Collier Neurologic Specialists

    Naples, Florida

  • Neurology Associates of Ormond Beach

    Ormond Beach, Florida

  • Consultants in Neurology, Ltd

    Northbrook, Illinois

  • Klinika Mjekesore Nuova, Neurology Clinic

    Tirana, Albania

  • Hygeia Hospital Tirana

    Tirana, Albania

  • University Hospital Center Mustapha Pacha, Algiers

    Algiers, Algeria

  • University Hospital Center Ibn Sina, Annaba

    Annaba, Algeria

  • University Hospital Center of Oran

    Oran, Algeria

  • MHAT Puls AD

    Blagoevgrad, Bulgaria

  • MHAT "Heart and Brain", EAD

    Burgas, Bulgaria

  • MC Exacta Medica OOD

    Pleven, Bulgaria

  • MHAT Avis Medica

    Pleven, Bulgaria

  • UMHAT Dr.Georgi Stranski EAD

    Pleven, Bulgaria

  • Heart and Brain University Hospital

    Pleven, Bulgaria

  • MC Vita 1

    Pleven, Bulgaria

  • UMHAT "Kaspela"EOOD

    Plovdiv, Bulgaria

  • UMHAT "Pulmed" Ltd

    Plovdiv, Bulgaria

  • UMHAT Sveti Georgi

    Plovdiv, Bulgaria

  • UMHAT "Medica Ruse"

    Rousse, Bulgaria

  • CCB Medical Institute Ministry of Interior

    Sofia, Bulgaria

  • Diagnostic and Consultative Center Neoclinic

    Sofia, Bulgaria

  • UMHAT "Sveti Ivan Rilski" EAD

    Sofia, Bulgaria

  • MHATNP "Sveti Naum", EAD

    Sofia, Bulgaria

  • MHATNPsy Sveti Naum EAD

    Sofia, Bulgaria

  • UMHAT "Alexandrovska" EAD

    Sofia, Bulgaria

  • UMHAT "Alexandrovska"

    Sofia, Bulgaria

  • Military Medical Academy MHAT

    Sofia, Bulgaria

  • MHAT "Sveta Sofia" EOOD

    Sofia, Bulgaria

  • Military Medical Academy

    Sofia, Bulgaria

  • UMHAT"Tsaritsa Yoanna -ISUL

    Sofia, Bulgaria

  • UMHATEM N.Pirogov

    Sofia, Bulgaria

  • UMHAT "Sveta Marina" EAD, First Clinic of Neurological Diseases

    Varna, Bulgaria

  • 1st Uni Clinic of Tbilisi LEPL

    Tbilisi, Georgia

  • Eristavi Experimental Center

    Tbilisi, Georgia

  • J.S.C. Curatio Clinic

    Tbilisi, Georgia

  • JSC "Jerarsi"

    Tbilisi, Georgia

  • Khechinashvili University Hospital

    Tbilisi, Georgia

Showing 40 of 103 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.